Eisler Capital (UK)’s Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 BSAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100,000
Closed -$79K 547
2021
Q4
$79K Sell
100,000
-100,000
-50% -$67.1K ﹤0.01% 308
2021
Q3
$110K Buy
+200,000
New +$104K ﹤0.01% 294

Other funds holding BSAQ.WS

Eisler Capital (UK)'s BSAQ.WS Position: Q1 2022 in Review

Eisler Capital (UK) sold out of Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (BSAQ.WS) in Q1 2022, closing a stake of 100,000 shares — an estimated $79K sold.

Eisler Capital (UK) first reported a position in BSAQ.WS in Q3 2021 and held it in 2 quarters. The position peaked at $110K in Q3 2021. 24 funds tracked by Wall St. Rank hold BSAQ.WS as of Q1 2022.

  • Eisler Capital (UK) reported no remaining Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Eisler Capital (UK) sold 100,000 Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $79K.
  • Eisler Capital (UK) first reported a position in Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 2 quarters.
  • Eisler Capital (UK)'s Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $110K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Eisler Capital (UK)'s 13F filing for Q1 2022, filed 16 May 2022.